National HealthCare Corporation (NHC) Stock Forecast and Price Target (2026)
Last updated July 2026
Short answer
There is no meaningful analyst consensus for National HealthCare Corporation (NHC): too few analysts publish estimates on it for an average target to mean anything. That is normal for smaller and newer companies and says nothing about the business. What is left is the setup, the drivers and the risks below, which you assess yourself rather than starting from someone else's model. Walnut is not an investment adviser.
Why NHC has no consensus price target
Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with NHC. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.
Second-quarter GAAP results were flattered by items that do not repeat: an $18.3 million catch-up of management fees recognized when the affiliate acquisition closed, plus mark-to-market gains on the securities portfolio. Adjusted net income of about $27.6 million, up 7.2% year over year, is the cleaner read on operations, and the gap between $2.54 GAAP and $1.74 adjusted diluted EPS shows how much noise the equity portfolio introduces. Trailing multiples also predate the July 1 NHI closing, so they reflect a rent-paying, debt-free company rather than the property-owning, leveraged one that exists today.
What could move NHC from here
In short: the drivers cited most often are Owning the buildings instead of renting them, Tuck-in acquisitions inside the existing footprint, Demographics and a diversified payor mix. The risk cited most often against it is roughly 29% of net patient revenue comes from Medicaid, and the 2025 federal reconciliation law tightens state provider-tax financing beginning in fiscal 2028, which could squeeze the state rates that fund those beds.
Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the NHC is it a buy page. This page deliberately stops at the numbers.
Investing in National HealthCare Corporation with AI
Connect the broker you already use and ask Walnut's AI how NHC fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the price target for National HealthCare Corporation (NHC)?
+
There is no meaningful consensus price target for NHC, because too few analysts publish on it. That is common for smaller and newer companies. Where only one or two analysts cover a stock, an "average target" is really one person's model, so we do not print a number that would imply more agreement than exists. Check your broker's research tab for whatever individual coverage exists.
Why does NHC have no analyst forecast?
+
Sell-side coverage follows trading volume and banking relationships, so small caps, recent listings, and companies outside the major indices often carry little or none. A lack of coverage says nothing about the business itself. It does mean you are doing the analysis yourself rather than starting from someone else's model.
What could move NHC?
+
The drivers and the risks are laid out on this page and in more depth on the NHC "is it a buy" page. Without analyst estimates to anchor to, the honest framing is scenarios rather than a number.
Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a August 2026 data pull of published third-party research, are approximate, and change constantly. Verify current figures with your broker before acting on them.